Bertrand Loy, Director at HARVARD BIOSCIENCE INC (HBIO), bought 13,857 shares at $3.23 ($44K) on 2022-08-23, disclosed to the SEC on 2022-08-24.
Open-market purchase of $44k HBIO by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.16 | 4,918 | $16K | 35.0% |
| 2 | $3.23 | 8,939 | $29K | 65.0% |
| Total | $3.21 avg | 13,857 | $44K | 100% |
| Filing → |
| ENTG | SELL | 2026-02-26 | $15.2M | — | Filing → |
| ENTG | SELL | 2026-02-04 | $7.8M | — | Filing → |
| ENTG | SELL | 2025-12-03 | $8.8M | — | Filing → |